InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Ashe Andrew D., Autre. Officer active across 2 companies, notably Verve Therapeutics, Inc.. In total, 14 disclosures have been logged. Split: 2 buys · 0 sell. Total volume traded: €553k. Activity tracked since 2 December 2021. The latest transaction was disclosed on 14 May 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Ashe Andrew D.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
348,828 sharesCommon StockSEC:0000950170-25-099254:0
9,000 sharesCommon StockSEC:0000950170-25-050561:0
76,000 shares@ US$6.2659.6% of flowCommon StockSEC:0000950170-24-060613:0
Canonical exit: 12 Aug 2024 (T+90)
51,203 shares@ US$1.399.7% of flowCommon StockSEC:0001209191-22-047882:0
4,000 shares@ US$32.104950.0% of flowCommon StockSEC:0000899243-21-046888:0
Canonical exit: 2 Mar 2022 (T+90)
331,528 sharesCommon StockSEC:0000908662-16-000426:0
625 sharesCommon StockSEC:0000908662-16-000394:0
5,150 sharesCommon StockSEC:0000908662-16-000394:1
18,125 sharesCommon StockSEC:0000908662-16-000394:2
38,750 sharesCommon StockSEC:0000908662-16-000394:3
54,688 sharesCommon StockSEC:0000908662-16-000394:4
51,563 sharesCommon StockSEC:0000908662-16-000394:5
66,000 sharesCommon StockSEC:0000908662-16-000394:6
62,500 sharesCommon StockSEC:0000908662-16-000394:7
14 of 14 declarations
About Ashe Andrew D.
Andrew D. Ashe is associated with Verve Therapeutics, Inc. Although his specific role is not detailed, he contributes to the strategic direction of the company. His expertise in the biotechnology field is an asset to Verve Therapeutics.
